LILLY ELI CO, (LLY) Stock Research Free Stock Rating

Company Profile

Eli Lilly and Company engages in the discovery, development, manufacture, and sale of primarily pharmaceutical products in the United States and internationally. The company’s products include neuroscience products, which include Zyprexa, Prozac, Strattera, Cymbalta, Permax, Symbyax, and Yentreve; endocrinology products that consist primarily of Humalog, Humulin, Actos, Evista, Forteo, and Humatrope; and oncology products, which comprise primarily of Gemzar and Alimta. It also offers cardiovascular products that consist primarily of ReoPro and Xigris; and anti-infectives, which primarily include Ceclor and Vancocin. The other pharmaceutical product group includes Cialis, Axid, and other miscellaneous pharmaceutical products and services. In addition, Eli Lilly offers animal health products that include Tylan, Rumensin, Coban, and other products for livestock and poultry. It primarily sells its pharmaceutical products through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. The company was founded by Eli Lilly in 1876. Eli Lilly and Company is based in Indianapolis, Indiana.

Latest Headlines

Targanta Tanks On Antibiotic Questions (at Forbes.com)

Early Glance: Pharmaceuticals companies (AP)

How to Become an Accidental Billionaire (at Motley Fool)

UPDATE - Pfizer pulls EU bid to sell non-prescription Viagra (at Reuters)

Ailing AstraZeneca (at Forbes.com)

AstraZeneca Trials Provide Zest and Zeal for OSI Pharmaceuticals (at Seeking Alpha)

Elan taps Lilly's Carlos Paya president (at MarketWatch)

Elan hires Lilly executive as company president (at Reuters)

Antibiotics: It's The Efficacy, Stupid (at Forbes.com)

Bristol-Myers Squibb Could Rise To Old Highs (at Investopedia)